VINCENT RICHARD G (Chief Financial Officer) purchased 23.6% of their position (30K shares) of ONCTERNAL THERAPEUTICS, INC. on the open market
Open‑market purchase worth $9.0K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/14/2023ACC: 0001209191-23-024263
Officer· Chief Financial Officer
Since Jun 2019
+30K
Net shares
Net buyer
$9.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
30K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+30K
Price / share
$0.30
Trade value
$8.96K
% of position
23.6%
4/13/2023
126.86K→156.86K
Total
Net shares
+30K
Net value
$8.96K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/13/2023 | P · Purchase | +30K | $0.30 | $8.96K | 23.6% | 126.86K | 156.86K |
| Total | +30K | $8.96K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned1.83K
Common Stock
IndirectShares owned4.53K
Total
6.36K indirect6.36K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.83K | Indirect |
| Common Stock | 4.53K | Indirect |
| Total | 6.36K | 6.36K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported